FDA.reportPublic FDA data

Zylet (loteprednol etabonate 0.5 % / tobramycin 0.3 % ) Ophthalmic Suspension

RxCUI
545259
RxNorm name
Zylet (loteprednol etabonate 0.5 % / tobramycin 0.3 % ) Ophthalmic Suspension
Display name
Zylet (loteprednol etabonate 0.5 % / tobramycin 0.3 % ) Ophthalmic Suspension
Full name
Zylet (loteprednol etabonate 0.5 % / tobramycin 0.3 % ) Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZyletLOTEPREDNOL ETABONATE AND TOBRAMYCINBausch & Lomb Incorporated3dd9b060-5355-404d-bdf1-09ee8b52a9f52022-04-30Warnings, Adverse reactionsExact identifier
rxcui: 545259

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3dd9b060-5355-404d-bdf1-09ee8b52a9f5Zylet 0.5 % / 0.3 % Ophthalmic Suspension [PSN] · loteprednol etabonate 5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [Zylet] [SBD] · Zylet (loteprednol etabonate 0.5 % / tobramycin 0.3 % ) Ophthalmic Suspension [SY] · Zylet (loteprednol etabonate 5 MG / tobramycin 3 MG) per ML Ophthalmic Suspension [SY]418These highlights do not include all the information needed to use ZYLET safely and effectively. See full prescribing information for ZYLET. ZYLET ® (loteprednol etabonate and tobramycin ophthalmic suspension) 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 200420220430